Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2022-06-03 00:00:00 ET · period of report 2022-06-01 · accession 0001209191-22-034343 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-03 | 2022-06-01 | ADPT | PETERSON TYCHO | CFO | A - Grant | $0.00 | +374.7K | 374.7K | New | $0 |
| D | 2022-06-03 | 2022-06-01 | ADPT | PETERSON TYCHO | CFO | A - Grant | $0.00 | +597.2K | 597.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-01 | A | A | 374,688 | $0.00 | 374,688 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-06-01 | A | A | 597,157 | $0.00 | 597,157 | D | $7.30 · — to 2032-06-01 | 597,157 Common Stock | (F1) The options vest with respect to 1/4 of such shares on June 1, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |